-
Product Name
THOC1 antibody
- Documents
-
Description
THOC1 Rabbit Polyclonal antibody. Positive WB detected in HEK-293 cells. Positive IHC detected in human colon cancer tissue. Observed molecular weight by Western-blot: 84 kDa
-
Tested applications
ELISA, WB, IHC
-
Species reactivity
Human,Mouse,Rat; other species not tested.
-
Alternative names
HPR1 antibody; hTREX84 antibody; Nuclear matrix protein p84 antibody; P84 antibody; P84N5 antibody; THO complex 1 antibody; THO complex subunit 1 antibody; Tho1 antibody; THOC1 antibody
- Immunogen
-
Isotype
Rabbit IgG
-
Preparation
This antibody was obtained by immunization of TH℃1 recombinant protein (Accession Number: NM_005131). Purification method: Antigen affinity purified.
-
Clonality
Polyclonal
-
Formulation
PBS with 0.1% sodium azide and 50% glycerol pH 7.3.
-
Storage instructions
Store at -20℃. DO NOT ALIQUOT
-
Applications
Recommended Dilution:
WB: 1:200-1:2000
IHC: 1:20-1:200
-
Validations
HEK-293 cells were subjected to SDS PAGE followed by western blot with Catalog No:116046(THoc1 antibody) at dilution of 1:500
Immunohistochemical of paraffin-embedded human colon cancer using Catalog No:116046(THoc1 antibody) at dilution of 1:100 (under 10x lens)
-
Background
THoc1 (THO complex subunit 1), also known as Tho1, P84, HPR1 or P84N5, is a 657 amino acid nuclear matrix protein and is evolutionarily conserved from yeast to humans. THoc1 contains one death domain and is a component of the heteromultimeric THO/TREX (transcription/export) complex along with THoc2, THoc3, BAT1 and ALY. The THO/TREX complex is recruited to transcribed genes and travels along with RNA polymerase II (Pol II) during elongation, coupling elongating Pol II with RNA splicing and export factors. THoc1 is expressed at high levels in breast cancer cells and at relatively low levels in normal epithelia. A reduction of THoc1 in cancer cell lines results in promoted cancer cell apoptosis and reduced cell proliferation. This suggests that cancer cells are dependent on the high levels of THoc1 expression and therefore THoc1 may be a good target for cancer therapy. This antibody recognizes the 84kd THoc1 protein.
-
References
- Lin YS, Lin CH, Huang LD. The suppression of thoc1 in cancer cell apoptosis mediated by activated macrophages is nitric oxide-dependent. Biochemical pharmacology. 86(2):242-52. 2013.
- Liu C, Yue B, Yuan C. Elevated expression of Thoc1 is associated with aggressive phenotype and poor prognosis in colorectal cancer. Biochemical and biophysical research communications. 468(1-2):53-8. 2015.
Related Products / Services
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"